Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
The Hematology Journal : the Official Journal of the European Haematology Association|July 23, 2003
Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60-75 years of age with multiple myeloma stages II and IIIJeanette Lundin, Anders Osterborg, Magnus Björkholm, et al.Cancer|April 28, 2006
A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of lifeJan Samuelsson, Hans Hasselbalch, Oystein Bruserud, et al.International Journal of Medical Sciences|April 17, 2008
TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disordersJan Palmblad, Magnus Björkholm, Jack Kutti, et al.Human Molecular Genetics|October 2, 2004
Disruption of a novel ectodermal neural cortex 1 antisense gene, ENC-1AS and identification of ENC-1 overexpression in hairy cell leukemiaMarianne Hammarsund, Mikael Lerner, Chaoyong Zhu, et al.Hematology (Amsterdam, Netherlands)|September 20, 2012
Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: results of a prospective long-term follow-upElisabeth Ejerblad, Hans M Kvasnicka, Jürgen Thiele, et al.Blood|February 15, 2003
Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitopeGerard Tobin, Ulf Thunberg, Anna Johnson, et al.Haematologica|April 12, 2005
Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcomeGerard Tobin, Ulf Thunberg, Anna Laurell, et al.Blood|June 26, 2004
Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemiaGerard Tobin, Ulf Thunberg, Karin Karlsson, et al.Proceedings of the National Academy of Sciences of the United States of America|June 20, 2007
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patientsAndrea Pellagatti, Martin Jädersten, Ann-Mari Forsblom, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01Francesco d'Amore, Thomas Relander, Grete F Lauritzsen, et al.Pageof 3